This quiz titled 'Practice for Pharmacodynamics Exam 3' assesses knowledge on migraine causes, triptan properties, contraindications, and appropriate medication substitutions. It is crucial for students and professionals in medicine, particularly those focusing on pharmacodynamics.
A) Sumatriptan
B) Eletriptan
C) Naratriptan
D) Frovatriptan
Rate this question:
True
False
Rate this question:
A) Use of ergotamine, DHE, or other ergot preparations within the prior 24 hours
B) Use of monoamine oxidase inhibitor (MAOI) within the past 2weeks due to increased risk of "serotonin syndrome"
C) Use of Acetylcholinesterase inhibitors
D) uncontrolled hypertension
A) decreased serotonin release
B) increased likelihood of emesis and nausea
C) Activation of 5HT3 receptors
D) b,c
E) a,b
Rate this question:
A) Yes, metoclopramide is an alternative anti-emesis drug
B) No, this drug may aggravate the patients Parkonsonism
C) No, this drug is indicated for nausea but contraindicated if the patient is vomiting
D) No, this drug will not have an effect in Parkinson’s patients due their lack of substancia nigra which is involved in metoclopramides mechanism of action
Rate this question:
A) No, there is no contraindication listed for these two medications
B) Contraindication in use of Lotronex is presence of hypertension
C) Contraindication is increased risk of constipation in addition to the risk already posed by alosetron
D) b and c
Rate this question:
A) Cyproheptadine has a side effect of increased sweating which may be resulting in dehydration
B) Cyproheptadine is antagonizing serotonin receptors in the gut
C) Cyproheptadine decreases thirst resulting is reduced water intake
D) Blockade of central muscarinic receptors
Rate this question:
A) Triptan’s work quicker
B) Triptan’s absorb better
C) Triptan’s do not have to be given with metoclopramide in certain patients to enhance gastric emptying and reduce nausea while using the drug
D) All of the above
Rate this question:
A) Increases release of NE and DA which will cause vasodilation
B) Inhibits endothelial release of nitric oxide
C) inhibits release of histamine from mast cells
D) a and b
E) b and c
Rate this question:
A) painful extremities
B) peripheral ischemia
C) nausea and vomiting
D) continuous paresthesias
Rate this question:
True
False
Rate this question:
A) Ergot alkaloids
B) Antidepressants
C) NSAIDs
D) Serotonin agonists
E) Acetaminophen
Rate this question:
A) Beta-blockers
B) Beta-blockers with intrinsic sympathomimetic activity
C) Anticonvulsants
D) Calcium channel blockers
Rate this question:
A) 5-HT1B and 5-HT1D
B) Dopamine
C) Norepinephrine
D) Cholinergic
Rate this question:
True
False
Rate this question:
A) Trigeminovascular
B) Perivascular
C) Extravascular
D) Tuberofundibular
Rate this question:
True
False
Rate this question:
A) cyproheptadine
B) mitotane
C) ketoconazole
D) aminoglutethimide
Rate this question:
A) adrenocorticotropic hormone
B) corticotropin-releasing hormone
C) melanocyte-stimulating hormone
D) renin
Rate this question:
A) zona glomerulosa
B) zona fasciculate
C) zona reticularis
D) medulla
Rate this question:
A) adrenal carcinoma
B) primary pigmented nodular adrenal disease
C) adrenal adenoma
D) pituitary adenoma
Rate this question:
A) Spironolactone
B) Mifepristone
C) Angiotensin receptor blockers
D) Partial adrenalectomy
Rate this question:
A) 5 tablets today OTD
C) 1 tablet every day for 5 days
B) 5 tablets today UD, 4 tablets on 2nd day UD, 4 tablets on 3rd day UD, 3 tablets on 4th day UD, 2 tablets on 5th day as directed, and 1 tablet on the 6th day UD (UD = as directed)
D) None of the above is appropriate
Rate this question:
A) Weight gain and insomnia often occur when starting treatment
B) Chronic use can lead to osteoporosis and glaucoma for which they must be monitored.
C) Patients should wear medical identification stating they are on chronic steroid therapy.
D) Patients may need to decrease dose during times of increased stress.
Rate this question:
A) CGRP
B) NK-A
C) bradykinin
D) Substance P
E) Actually, all of the above do cause vasodilation
Rate this question:
Excitatory ACh only stimulates M3 and M2 receptors
Serotonin acting at presynaptic 5-HT4 receptors increases the release of ACh and CGRP from submucosal IPANs
Erythromycin acts as an antagonist at motilin receptors
All o fthe above are actually true
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
It is a benzamide D2 receptor antagonist that enhances the motility of smooth muscle from the esophagus through the proximal small intestine
Facilitates gastric emptying from teh duodenum to the ileocecal valve
Increases receptive relaxation in the upper stomach and decreases antral contractions
Reduces reflux from the duodenum and the stomach into the esophagus
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
Hyperprolactemia
Extrapyramidal effects
Anti-emetic activity
Enhances gastric motility
Rate this question:
True
False
Rate this question:
True
False
Rate this question:
Increases intestinal fluid by activating and opening specific potassium channels in the luminal cells of the intestines
The drug is a bicyclic fatty acid, prostaglandin El (PGE1) derivative
Alters stool consistency and promotes regular bowel movements, without altering serum electrolyte concentrations or producing tolerance
The action of lubiprostone is observed only the apical (luminal) side of the intestinal epithelium
Rate this question:
It is a guanylate cyclase-C receptor agonist
Causes no major side effects other than increased incidence of stomach pain and flatulence
Treats chronic idiopathic constipation or irritable bowel syndrome with constipation
Not recommended for use in patients
Rate this question:
Quiz Review Timeline (Updated): Mar 21, 2023 +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
Wait!
Here's an interesting quiz for you.